Musculoskeletal research findings

Musculoskeletal research findings

  • Musculoskeletal research findings
Select Page
  • Musculoskeletal research findings
20 year outcomes of patients with rheumatoid arthritis

20 year outcomes of patients with rheumatoid arthritis

by Web team (HR) | Feb 8, 2019 | Rheumatoid arthritis

Musculoskeletal research findings What was already known? Rheumatoid arthritis (RA) is a chronic disease that is associated with joint inflammation. Previous studies have shown that, by 20 years after diagnosis, patients reported severe levels of disability and pain,...
Tumour necrosis factor inhibitor drugs reduce the occurence of heart attacks

Tumour necrosis factor inhibitor drugs reduce the occurence of heart attacks

by Web team (HR) | Feb 8, 2019 | Rheumatoid arthritis

Musculoskeletal research findings What was already known? Patients with rheumatoid arthritis (RA) are at higher risk of heart attacks (myocardial infarction; MI) than the general population, which is partly explained by the effect of inflammation associated with RA on...
Drug levels of tumour necrosis factor drugs influence response to treatment

Drug levels of tumour necrosis factor drugs influence response to treatment

by Web team (HR) | Feb 8, 2019 | Rheumatoid arthritis

Musculoskeletal research findings What was already known? Biologic drugs that are used to treat rheumatoid arthritis (RA) act by targeting inflammatory molecules in the body. They are usually very effective but, in about one in five patients where biologics work...
Missing doses of tumour necrosis factor drugs leads to poorer response rates

Missing doses of tumour necrosis factor drugs leads to poorer response rates

by Web team (HR) | Feb 8, 2019 | Rheumatoid arthritis

Musculoskeletal research findings What was already known? Anti-TNF drugs (e.g. etanercept, certolizumab, adalimumab and golimumab) are biologic drugs that have radically improved treatment options for patients with Rheumatoid Arthritis (RA). Currently, there are 4...
Gene variants show potential in predicting rheumatoid arthritis disease outcomes

Gene variants show potential in predicting rheumatoid arthritis disease outcomes

by Web team (HR) | Feb 8, 2019 | Rheumatoid arthritis

Musculoskeletal research findings What we found? Arthritis Research UK-funded scientists have identified a new way in which genotyping can be used to predict disease outcomes among sufferers of rheumatoid arthritis. New cohort studies have shown that certain genetic...
« Older Entries
Next Entries »

Categories

  • Inflammatory myositis
  • Juvenile idiopathic arthritis
  • Osteoarthritis
  • Pain and fatigue
  • Psoriatic arthritis
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Systemic sclerosis
  • Uncategorised

Recent Posts

  • Incidence and Prevalence of Juvenile Idiopathic Arthritis in the UK
  • BSR Best Practice Award winner: supporting rheumatoid arthritis patients to take their medication
  • How the weather affects the pain of citizen scientists using a smartphone app
  • Chromatin interactions reveal novel gene targets for drug repositioning in rheumatic diseases
  • The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data.

Recent Comments

    Archives

    • November 2021
    • July 2020
    • April 2020
    • February 2020
    • August 2019
    • July 2019
    • June 2019
    • March 2019
    • February 2019

    Popular

    Sorry. No data so far.

    • Facebook
    • Twitter
    • Google
    • RSS

    Designed by Elegant Themes | Powered by WordPress

    • Disclaimer /
    • Privacy /
    • Copyright notice /
    • Accessibility /
    • Freedom of information /
    • Charitable status /
    • Royal Charter Number: RC000797
    Tweets by UoMMskResearch
    The University of Manchester